ONCOLOGY
Neoscreen in the field of molecular oncology proposes molecular tests for individualized therapy (immunotherapy) and extraction of molecular profiles (TMB, PDL1, MSI) of various types of tumors (solid tumors) and liquid biopsy, using large panels (> 500 genes ) carried out in collaboration with major international genetic testing centers, such as BGI. See the link below:
Being aware of the status of genetic tests in Greece, but also the international data from reputable centers abroad, we consider that we offer genetic tests of molecular oncology of high diagnostic value, accredited by international standards, equal or upgraded to those already offered in the Greek market, at an extremely competitive price, reaching up to 50% of the cost of corresponding packages.